Skip to main content
. 2021 Jan 15;11:537565. doi: 10.3389/fneur.2020.537565

Table 2.

Clinical data of patients who underwent both cerebral and hepatic alveolar echinococcosis (AE) operation.

Case no. Age/ sex Main symptoms Cerebral location Other location Treatment Cerebral AE surgery Degree of cerebral surgery Duration of ABZ therapy (Regularity) AE duration (mths)a Max mRS/ GCS at post-IOp Time to recurrence Outcomes (follow-upb)
8 46/M Epilepsy Left PO Liver, Lung HOp + ABZ +IOp Left occipital and parietal lobectomy Completely removed 3 years (Regular) 60 mths 2/15 1 mth Alive (20 mths)
9 49/M Headache, Dizziness Left O Liver, Lung, Kidney Hop + ABZ + IOp Left occipital lobectomy Completely removed 3 years (Regular) 72 mths 0/15 None Alive (22 mths) Headache
13 24/F Headache, Epilepsy, Vomiting Multiple Liver, Lung HOp + ABZ + IOp Left frontal and occipital lobectomy Partially removed 2 years (Regular) 108 mths NA NA Dead (39 mths)
18 51/F Headache, Dizziness Multiple Liver, Lung HOp + ABZ +IOp Left occipital and parietal lobectomy Partially removed 1 years (Regular) 132 mths NA NA Dead (21 mths)
21 69/F Stomachache Right thalamus Liver ABZ + HOp + IOp Right thalamic lobectomy Completely removed 1 years (Regular) 24 mths NA None Dead (24 mths)

F, female; M, male; T, temporal lobe; O, occipital lobe; PO, parieto-occipital lobe; AE, alveolar echinococcosis; IOp, intracranial AE operation; HOp, hepatic AE operation; ABZ, albendazole; Max, maximum; mRS, modifified Rankin Scale; GCS, Glasgow coma scale; mth, month; NA, not applicable.

a

Course of disease, duration from AE onset until death or last follow-up (months).

b

Follow-up, duration of follow-up after discharge (months).